Do Involuntary Movements have a Hold on You?

We invite those 18 to 85 years old who are experiencing involuntary movements in their face or other parts of their body- and suffer from schizophrenia, schizoaffective disorder, bipolar disorder, or mood disorder- to see if they qualify for the Kinect 3 Study. The purpose of this clinical research study is to evaluate the effectiveness, safety, and tolerability of an investigational oral medication for tardive dyskinesia.

Each individual will be evaluated to determine his or her eligibility. Those who qualify will receive study medication, study-related medical exams, and lab tests at no charge. Compensation for time and travel may also be available.

Participants will be screened for eligibility and if deemed eligible, will receive the medication for the study treatment period of 48 weeks (which includes 16 in-office visits and a follow-up appointment four weeks after completing study treatment). Throughout the study, participants will continue to receive regular general health check-ups and monitoring of TD symptoms.

Segal Institute will be conducting this clinical trial at 3 sites:

North Miami Outpatient Clinic

1065 Northeast 125th Street, Suite 417

North Miami, Florida 33161

Phone: (305) 722-8447


West Broward Outpatient Clinic

7481 West Oakland Park Boulevard, Suite 205

Lauderhill, FL 33319

Phone: (954) 990-6326


Charleston Outpatient Clinic

1483 Tobias Gadson Blvd, Suite 107

Charleston, SC 29407

Phone: (843) 576-6750

Want more information?

Join our

Be the first to know about our new studies! You can unsubscribe at any time.